A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients

Phase 3 Completed 168 enrolled Astellas Pharma Inc

RandomizedParallel-groupQuadruple-blindTreatment

This study is to evaluate the efficacy and safety after concomitant administration of ASP1941 and metformin in patients with diabetes mellitus.

Evaluation	Drug	Modality	Dose	Route
Subject	ipragliflozin	Small molecule	—	Oral
Background	Metformin	Small molecule	—	Oral